Form 4 for ELAN Elanco Animal Health Inc
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001415889-23-004289 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-03 | 2023-03-01+ | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | F - Tax | $11.16 | -21.8K | 974.8K | -2% | -$243.3K |
| D | 2023-03-03 | 2023-03-01 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +248.7K | 991.0K | +33% | $0 |
| D | 2023-03-03 | 2023-03-01 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +568.0K | 568.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | F | D | 12,662 | $11.26 | 742,369 | D | — | — | (F1) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. (F2) Includes 2,045 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022. |
| 2 | Common | Common Stock | 2023-03-01 | A | A | 248,668 | $0.00 | 991,037 | D | — | — | (F3) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. |
| 3 | Common | Common Stock | 2023-03-02 | F | D | 9,149 | $11.01 | 974,761 | D | — | — | (F1) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. (F4) Balance reflects 7,127 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | A | A | 567,952 | $0.00 | 567,952 | D | $11.26 · — to 2033-03-01 | 567,952 Common Stock | (F5) Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. |